Content
All Posts > Content under Pharma/Biotech
8 Monster Stocks To Watch For The Week Of May 25
Article By:
Michael J. Kramer
Read
Sunday, May 24, 2020 1:42 PM EDT
The market left itself in a vulnerable spot to start the final week of May. Trends overall are not all that bullish as the index continues to post signs of fading momentum.
Guardant Health: Strong Momentum And Enormous Opportunities
Article By:
Andres Cardenal
Read
Sunday, May 24, 2020 12:39 PM EDT
Guardant Health (GH) is a high growth business with enormous potential and truly disruptive technologies. A position in Guardant Health carries significant risks. However, the long term upside potential may well be worth the risk.
Weighing The Week Ahead: A Search For Balance In The Great Reopening
Article By:
Jeff Miller
Read
Sunday, May 24, 2020 3:57 AM EDT
The economic calendar features many important reports – housing, consumer confidence, personal income, personal spending, and the Fed’s Beige Book. We now have April data for economic reports and May data for confidence.
Profit From The Genomics Market Momentum With These ETFs
Article By:
Zacks Investment Research
Read
Saturday, May 23, 2020 7:04 PM EDT
It appears that growing demand for personalized medicine, solid investments and higher R&D activities can make genomics the next big thing in the investing space. We highlight a host of ETFs that investors can keep tabs on.
Week In Review: How Trump's Policies Moved Stocks - Saturday, May 23
Cannabis Central: Pot Stock Index Up 3.6% On Friday; Aurora Down 8%
Article By:
Lorimer Wilson
Read
Saturday, May 23, 2020 4:47 PM EDT
The Non-Penny Pot Stock Index (NPSI) was UP 3.6% Friday with 30 of the 38 constituents advancing. In addition, 8 of the 9 industry categories advanced. Aurora declined the most (-8%) on the day but was still up 42.9% for the week.
In this article: CGC, ZYNE, GRWG, ABAHF, MEDIF, KERN, VFF, ACRGF, CRON, LQSIF, AYRWF, NEPT, VLNCF, TLRY, ACB, HEXO, YCBD, IIPR, NBEV
Atara Jumps After Data Released On Multiple Sclerosis Study
Article By:
The Fly
Read
Saturday, May 23, 2020 3:19 PM EDT
Data to be presented at the virtual European Academy of Neurology meeting next week in a late-breaking abstract related to ATA188, an allogeneic cell therapy being developed by Atara Biotherapeutics, has been released.
In this article: ATRA
Week In Review: CanSino Publishes Positive Data From Trial Of COVID-19 Vaccine
Article By:
ChinaBio® Today
Read
Saturday, May 23, 2020 2:41 PM EDT
Tianjin CanSinoBIO published positive results from a China Phase I trial of its COVID-19 vaccine in the prestigious British journal, The Lancet. In the study, the Ad5 vectored COVID-19 vaccine was immunogenic at 28 days post-vaccination.
Hikma Receives FDA Approval For Generic Of Amarin's Vascepa
Article By:
The Fly
Read
Friday, May 22, 2020 7:42 AM EDT
Hikma Pharmaceuticals announced overnight that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA has received approval from the Food and Drug Administration for its Icosapent Ethyl Capsules, the generic equivalent to Amarin's Vascepa.
Cannabis Central: Pot Stock Index Up 3.5% On Thursday
Article By:
Lorimer Wilson
Read
Friday, May 22, 2020 3:58 AM EDT
The Non-Penny Pot Stock Index was Up 3.5% Thursday with 7 of 9 industry categories advancing. Aurora was the major mover, yet again, up +36.5% following a -13% on Wednesday, -14% on Tuesday, +53% on Monday and +69% the previous Friday.
CanSino Biologics Shares Rose 380% As COVID-19 Vaccine Promise Emerges
Cannabis Central's Pot Stock Index Was Up On Wednesday But Aurora Was Down 13%
Article By:
Lorimer Wilson
Read
Thursday, May 21, 2020 4:02 AM EDT
The NPSI had a slight increase on Wednesday (+0.9%) with 6 of the 9 industry categories advancing. Aurora, however, declined a further 13% on the heels of a 14% decline on Tuesday compared to gains of 52.7% on Monday and 68.7% the previous Friday.
Cannabis Central: Pot Stock Index Continued Up On Tuesday
Article By:
Lorimer Wilson
Read
Wednesday, May 20, 2020 3:49 AM EDT
The Non-Penny Pot Stock Index (NPSI) had a slight increase on Tuesday (+0.7%) with all but one of nine industry category advancing. Aurora declined (-14.3%) compared to gains of 68.7% last Friday and 52.7% on Monday.
Market Briefing For Tuesday, May 19
Article By:
Gene Inger
Read
Tuesday, May 19, 2020 4:01 AM EDT
The market was a market waiting for good news and had been hanging-out in the 50-200 Daily Moving Average trading range. That does not mean it's not going to do much more, but for now, say a push toward S&P 3000, maybe 3100, but not much more.